Sign inGet started

COLONNESE MARK P

Insider CIK 1040766 · TBIO.OB Chief Financial Officer · BPTH Director · BOTA Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BPTH BIO-PATH HOLDINGS INC A Award deriv2019-03-282019-04-011,000— $01,000SEC↗
BPTH BIO-PATH HOLDINGS INC A Award deriv2018-04-172018-04-1920,000— $020,000SEC↗
BPTH BIO-PATH HOLDINGS INC A Award deriv2017-07-132017-07-1725,000— $025,000SEC↗
AVIR Aviragen Therapeutics, Inc A Award deriv2017-04-032017-04-05400,000$0.66 $264.0K775,000SEC↗
AVIR Aviragen Therapeutics, Inc A Award deriv2016-07-272016-07-29150,000$1.34 $201.0K375,000SEC↗
BOTA Biota Pharmaceuticals, Inc P Buy2016-02-092016-02-09300$1.40 $420300SEC↗
BOTA Biota Pharmaceuticals, Inc P Buy2016-02-092016-02-096,700$1.41 $9.4K7,000SEC↗
BOTA Biota Pharmaceuticals, Inc A Award deriv2015-11-022015-11-03225,000$2.02 $454.5K225,000SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2014-02-182014-02-207,000— $07,000SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2014-02-182014-02-207,000— $07,000SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2014-02-182014-02-207,000— $07,000SEC↗
TBIO TRANSGENOMIC INC A Award deriv2013-09-302013-10-03690,000— $0690,000SEC↗
TBIO TRANSGENOMIC INC A Award deriv2013-09-302013-10-07660,000— $0660,000SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2013-05-032013-05-0766,667— $066,667SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2013-05-032013-05-0766,667— $066,667SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2013-05-032013-05-0766,666— $066,666SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2012-09-122012-09-1783,333— $083,333SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2012-09-122012-09-1783,333— $083,333SEC↗
TBIO.OB TRANSGENOMIC INC A Award deriv2012-09-122012-09-1783,334— $083,334SEC↗